Loading
Life sciences · Journal article
Cellular and Molecular Bioengineering · October 6, 2026
No summary has been generated for this record yet. What follows is drawn from its source metadata only.
Journal article.
No findings were extractable from the material analysed.
Safety was not reported in the material analysed. Check the source before drawing any conclusion about harm.
The source did not state who this applies to in practice.
Graded across the dimensions that decide whether you should act, each from what the source actually supports. There is no single score, and where a dimension was not assessed it says so.
This record has not been graded across any dimension yet. Treat the label above as provisional and read the source.
What is missing. This record has no bottom line, key findings, reported figures, evidence dimensions. That is a gap in the analysis, not a judgement about the study.
Abstract Glioblastoma (GBM) is a highly aggressive brain tumor with limited treatment options and poor survival rates. In this study, we investigate the potential of peanut-shaped and sphere-shaped microparticles as microrobots for targeted GBM therapy, specifically using the U87 GBM cell line as a model. Our findings demonstrate that both peanut and sphere-shaped microparticles effectively decrease U87 cell viability in a dose-dependent manner (61–77% viability with peanuts and 81-27% viability with spheres between 12.5 and 400 μg/ml dosage), while also significantly reducing cell proliferation. We also compare our results with GBM cells to HMC3 cells as a control. This study highlights the therapeutic potential of these microparticle microrobots in reducing key hallmarks of GBM progression and opens up new possibilities for their application in precision cancer therapies using novel microrobot-based strategies.